The solution contains 0.30% citric acid anhydrous, 2.63% trisodium citrate dihydrate, 0.193% sodium phosphate monobasic anhydrous, and 2.32% glucose anhydrous, all w/v.
C7165
Citrate-phosphate-dextrose solution
aseptically filled
Synonym(s):
Citrate-phosphate-glucose
Sign Into View Organizational & Contract Pricing
Select a Size
50 ML
$66.60
10 X 50 ML
$456.00
All Photos(1)
Select a Size
Change View
50 ML
$66.60
10 X 50 ML
$456.00
About This Item
UNSPSC Code:
12161700
NACRES:
NA.25
Recommended Products
General description
Citrate-phosphate-dextrose solution (CPD) is an anticoagulant solution. It has 15% less citrate ion over citrate-phosphate-dextrose solution with adenine (ACD) and provides improved isotonicity, oxygen release function and posttransfusion viability for red blood cells.[1]
Application
Other Notes
Suggested anticoagulant: whole blood ratio: 1:14
Storage Class Code
10 - Combustible liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion
McCullough J and Weiblen BJ
Minnesota Medicine, 56(11), 980-982 (1973)
J J Macoskey et al.
Physics in medicine and biology, 63(5), 055013-055013 (2018-02-10)
Histotripsy is an ultrasonic tissue ablation method based on acoustic cavitation. It has been shown that cavitation dynamics change depending on the mechanical properties of the host medium. During histotripsy treatment, the target-tissue is gradually fractionated and eventually liquefied to
Noninvasive thrombolysis using histotripsy beyond the intrinsic threshold (microtripsy)
Zhang X, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 62(7), 1342-1355 (2015)
C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat
Croner RS, et al.
Microvascular Research, 67(2), 182-191 (2004)
Real-time feedback of histotripsy thrombolysis using bubble-induced color Doppler
Zhang X, et al.
Ultrasound in Medicine & Biology, 41(5), 1386-1401 (2015)
-
Provide the ingredients if available for CPD Catalog #C7165?
1 answer-
Helpful?
-
-
For the anticoagulant Product C7165, Citrate-Phosphate-Dextrose solution, what is the proper anticoagulant to whole blood ratio to use?
1 answer-
Our search of the literature shows that Citrate-Phosphate-Dextrose solution is typically used at a ratio of 1:7 or 1:9, but we do indeed test it at 1:14...the thinking being that if it works at 1:14, it will surely work at 1:7 or 1:9. The description of Product C7165, Citrate-Phosphate-Dextrose solution, suggests using it at an anticoagulant to whole blood ratio of 1.4 to 10 (about 1:7), but the specification sheet shows that it is tested at an anticoagulant to whole blood ratio of 1:14.
Helpful?
-
-
What is the Department of Transportation shipping information for this product?
1 answer-
Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.
Helpful?
-
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
